Preventing ischemic stroke

References

• 2000 heart and stroke statistical update. Dallas: American Heart Assoc, 2000
   Google Scholar
• Hademenos G. Metro Stroke Task Force: first-year experience. Stroke 1999; 30(11): 2512
   Google Scholar
• Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease: part II. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335(8693): 827–38
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265(24): 3255–64
   PubMed Web of Science ®Google Scholar
• Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989; 298(6676): 789–94
   PubMed Web of Science ®Google Scholar
• Wolf PA, D'Agostino RB, Kannel WB, et al. Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA 1988; 259(7): 1025–9
   PubMed Web of Science ®Google Scholar
• Warlow C. Endarterectomy for asymptomatic carotid stenosis? Lancet 1995; 345(8960): 1254–5
   Google Scholar
• Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273(18): 1421–8
   PubMed Web of Science ®Google Scholar
• Elkind MS, Sacco RL. Stroke risk factors and stroke prevention. Semin Neurol 1998; 18(4): 429–40
   Google Scholar
• Gorelick PB. Stroke prevention. Arch Neurol 1995; 52(4): 347–55
   Google Scholar
• Hart RG, Sherman DG, Easton JD, et al. Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology 1998; 51(3): 674–81
   Google Scholar
• Hart RG, Benavente O, McBride R, et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a metaanalysis. Ann Intern Med 1999; 131(7): 492–501
   PubMed Web of Science ®Google Scholar
• Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized clinical trials. Arch Intern Med 1994; 154(13): 1449–57
   PubMedGoogle Scholar
• Sacco RL, Gan R, Boden-Albala B, et al. Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke 1998; 29(2): 380–7
   PubMedGoogle Scholar
• Abbott RD, Donahue RP, MacMahon SW, et al. Diabetes and the risk of stroke: the Honolulu Heart Program. JAMA 1987; 257(7): 949–52
   Google Scholar
• Barrett-Connor E, Khaw KT. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol 1988; 128(1): 116–23
   Google Scholar
• Demchuk AM, Hess DC, Brass LM, et al. Is cholesterol a risk factor for stroke? Yes. Arch Neurol 1999; 56(12): 1518–20
   PubMedGoogle Scholar
• Landau WM. Is cholesterol a risk factor for stroke? No. Arch Neurol 1999; 56(12): 1521–4
   Google Scholar
• Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344(8934): 1383–9
   PubMed Web of Science ®Google Scholar
• Crouse JR 3d, Byington RP, Hoen HM, et al. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med 1997; 157(12): 1305–10
   Google Scholar
• Bucher HC, Griffith LE, Guyatt GH. Effect of HMGcoA reductase inhibitors on stroke: a meta-analysis of randomized, controlled trials. Ann Intern Med 1998; 128(2): 89–95
   PubMed Web of Science ®Google Scholar
• Pedersen TR, Kjekshus J, Pyorala K, et al. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol 1998; 81(3): 333–5
   PubMed Web of Science ®Google Scholar
• Plehn JF, Davis BR, Sacks FM, et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. Circulation 1999; 99(2): 216–23
   PubMed Web of Science ®Google Scholar
• Whisnant JP. Natural history of transient ischemic attack and ischemic stroke. In: Whisnant JP, ed. Stroke: populations, cohorts, and clinical trials. Oxford: Butterworth Heinemann, 1993: 135–53
   Google Scholar
• Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321(3): 129–35
   PubMed Web of Science ®Google Scholar
• Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. BMJ 1988; 296(6618): 313–6
   PubMed Web of Science ®Google Scholar
• Dyken ML. Antiplatelet agents and stroke prevention. Semin Neurol 1998; 18(4): 441–50
   Google Scholar
• North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325(7): 445–53
   PubMed Web of Science ®Google Scholar
• Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998; 339(20): 1415–25
   PubMed Web of Science ®Google Scholar
• European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial. Lancet 1998; 351(9113): 1379–87
   PubMed Web of Science ®Google Scholar
• International Stroke Trial Collaborative Group. The International Stroke Trial (1ST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet 1997; 349(9065): 1569–81
   PubMed Web of Science ®Google Scholar
• CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 1997; 349(9006): 1641–9
   Google Scholar
• Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308(6921): 81–106
   PubMed Web of Science ®Google Scholar
• van Gijn J, Algra A. Secondary stroke prevention with drugs: single or combined therapy? Cerebrovasc Dis 1999; 9(Suppl 3): 24–8
   Google Scholar
• Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143(1–2):1–13
   PubMed Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation Investigators. Risk factors for thromboembolism during aspirin therapy in atrial fibrillation: the Stroke Prevention in Atrial Fibrillation Study. J Stroke Cerbrovasc Dis 1995; 5(3): 147–57
   Google Scholar
• SPAF Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA 1998; 279(16): 1273–7
   Google Scholar